Loading...
Advancing New Mechanisms and Emerging Treatments in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Category
Sponsor

Pfizer

Share

Advancing New Mechanisms and Emerging Treatments in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Deadline: Oct 14, 2025
masters | phd | postdoctoral
partially funded
United States, Europe
To Apply

Please visit the application link below to apply.

Opportunity Overview
Benefits
Tags
mCRPC
Prostate Cancer
Medical Education
Reading papers feels like a chore?

Skip the struggle of dense PDFs. Our multilingual audio briefs turn complex research into clear, engaging summaries, perfect for learning while walking, commuting, or cooking.

Skip the struggle of dense PDFs. Our multilingual audio briefs turn complex research into clear, engaging summaries, perfect for learning while walking, commuting, or cooking.